Johnson & Johnson's organic growth and margin expansion remain moderate. Read why I would not add fresh capital to JNJ stock ...
Walmart is a one-stop shop. It sells groceries, toiletries, cleaning products, clothing, and other items people use in their ...
Zacks.com on MSN
How AbbVie's Pipeline Is Lining Up Key Product Launches
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Earnings reports are typically issued a few weeks after the end of each quarter, so there are four "earnings seasons" ...
MarketBeat on MSN
3 healthcare giants just raised dividends: Here's who pays the most
Major players in healthcare are increasing their commitments to return capital to shareholders, resulting in significantly ...
Cryptopolitan on MSN
Bitcoin crashes to $85,000 yet again, for absolutely no logical reason
We’re talking another slide from the low-$92k area down toward ~$87,000 over the weekend, and yeah, it’s messy because ...
Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...
Discover why iShares Core Dividend Growth ETF (DGRO) is a strong buy for consistent dividend growth. Click here to read my ...
Monte Rosa reports interim Phase 1/2 data showing durable responses and manageable safety for MRT-2359 plus Pfizer's Xtandi ...
The October and November jobs reports are expected this morning. Follow along for live updates on the Dow, S&P 500, Nasdaq and other markets.
MarketBeat on MSN
Pfizer: Can $108B Bet on Obesity Drugs Revive Its Struggling Stock?
Grand View Research found that North America accounts for the largest revenue share, with more than 75% of the GLP-1 agonists market. While other alternative obesity interventions exist, including ...
Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways that could accelerate oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results